2008 Publications

Sun SY. Therapeutic potential of synthetic triterpenoids in neuroblastoma. (Commentary) Cancer Biol Ther 7( 5), 2008. PMID: 18379197
Click for Abstract

Wang X, Chen Z, Yang L, Shin DM. Application of nanotechnology in cancer therapy and imaging. CA: A Cancer J for Clinicians 58(2):97-110, 2008. PMID: 18227410
Click for Abstract

Cho KJ, Wang X, Nie S, Chen Z(G), Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14(5):1310-1316, 2008. PMID: 18316549
Click for Abstract

McLean N, Tighiouart M, Muller, SL. Primary Mucosal Melanoma of the Head and Neck. Comparison of Clinical Presentation and Histopathologic Features of Oral and Sinonasal Melanoma. Oral Oncol, 2008 Apr 5; [Epub ahead of print]. PMID: 18396446
Click for Abstract

MullerSL, Tighiouart M, Saba N, Zhang H, Shin DM, Chen Z. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and non-metastatic head and neck squamous cell carcinoma: Predictive and prognostic correlation. Cancer, 2008 May 12; [Epub ahead of print]. PMID: 8473353
Click for Abstract

Parker KP, Bliwise DL, Ribeiro M, Jain SR, Vena CI, Kohles-Baker MK, Rogatko A, Xu Z, Harris WB. Sleep/Wake patterns of individuals with advanced cancer measured by ambulatory polysomnography. J Clin Oncol, 26(15):2464-72, 2008. PMID: 18487566
Click for Abstract

Kang S, Dong S, Gu T, Guo A, Lonial S, Khoury HJ, Polakiewicz RD, Chen J. EGF stimulates RSK2 activation through activation of the MEK/ERK pathway and Src-dependent tyrosine phosphorylation of RSK2 at Y529. J Biol Chem, 283( 8): 4652-7, 2008. PMID: 18156174
Click for Abstract

Shoji M , Sun A, Kisiel W, Lu YJ, Shim H, McCarey BE, Nichols C, Parker ET, Pohl J, Mosley CA, Alizadeh AR, Liotta DC, Snyder JP. Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa. J Drug Target. 16( 3): 185-97, 2008. PMID: 18365880
Click for Abstract

Raja SM, Chen S, Yue P, Acker TM, Lefkove B, Arbiser J, Khuri FR, Sun SY. The natural product honokiol preferentially inhibits c-FLIP and augments death receptor-induced apoptosis. Mol Cancer Ther, accepted pending a minor revision, 2008.

Kasinksi AL, Du Y, Thomas SL, Zhao J, Shoji M, Wang CW, Sun SY, Khuri FR, Sun A, Snyder JP, Liotta DC, Fu H. Potent inhibition of IKK and the NF-B signaling pathway by a novel monoketone analogue of curcumin. Mol. Pharm. 2008 (under revision).

Sun A, Lu YJ, Hu H, Shoji M, Liotta DC, Snyder JP. Water soluble curcumin analogs and cytotoxicity against breast cancer cells. Org. Lett. 2008, submitted.

Peng X-H, Qian X, Mao H, Wang AY, Chen Z, Nie S, Shin DM. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine, In Press, 2008.

Zhang X, Zhang HZ, Tighiouart M, Shin HJ, Khuri FR, Chen Z, Shin DM. Synergistic tumor growth inhibition by combined treatment with green tea epigallocatechin-3-gallate (EGCG) and EGFR tyrosine kinase inhibitor (TKI) in squamous cell carcinoma of the head and neck. Int J Cancer(In press), 2008.

Haddad RI and Shin DM. Recent Developments in Head and Neck Cancer. New Eng J. Med (In press), 2008.

Su L, Wang D, Zhang H, Shin DM, Chen ZG. Loss of E-cadherin induces proliferation of head and neck cancer through EGFR signaling pathway. Proc Am Assoc Cancer Res 49:1273a Abstract #5355, 2008.

Amin AR , Zhang X, Khuri FR, Chen ZG, Shin DM. Inhibition of Erlotinib-induced checkpoint but not apoptotic targets by EGCG: Implication for their anti-tumor synergism in squamous cell carcinoma of the head and neck. Proc Am Assoc Cancer Res 49:500a Abstract #2123, 2008.

Wang X, Li J, Cho KJ, Nannapaneni S, Tighiouart M, Chen ZG, Nie S, Shin DM. Pharmacology: Nanoparticles and new drug delivery strategies. Proceedings from the 2008 AACR, Abstract #5730, 2008.

Peng XH , Wang AY, Mao H, Chen ZG, Nie S, Shin DM: Imaging Agents and radiotherapeutics. Proceedings from the 2008 AACR, Abstract #3163, 2008.